The new Center is well-positioned to become a world-renowned leader for scientific discovery in translational and molecular discovery related to the pathogenesis and treatment of metabolic disease.
With more than 200 pulmonary disorders that fall under the umbrella of ILD, patient evaluation, proper diagnosis, and determining the best treatment is of the utmost importance.
Drs. Gregory Sonnenberg, Jeremy Goc, and Manish Shah have discovered that innate lymphoid cells protect against colorectal cancer, in part, by helping to maintain a healthy dialogue between the immune system and gut microbes.
The HOPE (HIV Obstruction by Programmed Epigenetics) Collaboratory represents a completely new strategy for curing HIV. Utilizing previous knowledge regarding how other viruses have become naturally inactivated over time, the HOPE approach aims to silence and permanently remove HIV from the body.
Dr. Goncalves and colleagues have published a paper in Nature demonstrating that a high-fructose diet promotes the elongation of intestinal villi.
As part of The Martin Delaney Collaboratories, which is an NIH flagship funding mechanism, Dr. Jones will be leading REACH (Research Enterprise to Advance a Cure for HIV) in pursuit of a cure for HIV.
The research from Drs. Ndhlovu and Corley finds that abrupt and altered cell-type specific DNA methylation profiles in blood, seen during acute HIV infection, persist despite prompt initiation of antiretroviral therapy.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 23.
The exciting new algorithm, MethSig, analyzes the thousands of DNA methylation changes detected in tumor cells and infers which ones are likely driving tumor growth.
